Clinical and Haematological Effects of Hydroxyurea in β-Thalassemia Intermedia Patients.

about

Trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in Southern Iran, 1995-2016: A retrospective cohort study.

P2860

Q47137705-50E1C68E-20D1-47A2-8D37-7281D8FC891F

P2860

Clinical and Haematological Effects of Hydroxyurea in β-Thalassemia Intermedia Patients.

Item

http://www.wikidata.org/entity/Q40334323

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clinical and Haematological Effects of Hydroxyurea in β-Thalassemia Intermedia Patients.

@en

type

Item

label

Clinical and Haematological Effects of Hydroxyurea in β-Thalassemia Intermedia Patients.

@en

prefLabel

Clinical and Haematological Effects of Hydroxyurea in β-Thalassemia Intermedia Patients.

@en

P1476

Clinical and Haematological Effects of Hydroxyurea in β-Thalassemia Intermedia Patients.

@en

P2093

Bijan Keikhaei

http://www.w3.org/2001/XMLSchema#string

Homayon Yousefi

http://www.w3.org/2001/XMLSchema#string

Mohammad Bahadoram

http://www.w3.org/2001/XMLSchema#string

P2860

β-thalassemia intermedia: a clinical perspective

Hydroxyurea therapy in 49 patients with major beta-thalassemia.

α:Non-α and Gγ:Aγ globin chain ratios in thalassemia intermedia patients treated with hydroxyurea.

Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model.

Side effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia.

Hydroxyurea for the treatment of sickle cell disease.

Hydroxyurea-induced hematological response in transfusion-independent beta-thalassemia intermedia: case series and review of literature.

Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia.

Guidelines for diagnosis and management of Beta-thalassemia intermedia.

Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India.

P304

OM01-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7860/JCDR/2015/14807.6660

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bijan Keikhaei

Homayon Yousefi

Mohammad Bahadoram

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26557561

http://www.w3.org/2001/XMLSchema#string

P932

4625280

http://www.w3.org/2001/XMLSchema#string

Clinical and Haematological Effects of Hydroxyurea in β-Thalassemia Intermedia Patients.

about

P2860

P2860

Clinical and Haematological Effects of Hydroxyurea in β-Thalassemia Intermedia Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932